These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 9123152)
1. Benefits of photopheresis in the treatment of heart transplant patients with multiple/refractory rejection. Dall'Amico R; Montini G; Murer L; Andreetta B; Tursi V; Feltrin G; Guzzi G; Angelini A; Zacchello G; Livi U Transplant Proc; 1997; 29(1-2):609-11. PubMed ID: 9123152 [No Abstract] [Full Text] [Related]
2. Optimal timing for surveillance endomyocardial biopsies in heart transplant patients receiving antithymocyte globulin induction. Cantarovich M; de Gruchy S; Forbes C; Marpole D; Elstein E; Magnan C; de Varennes B Transplant Proc; 1999; 31(1-2):79. PubMed ID: 10083015 [No Abstract] [Full Text] [Related]
3. Tacrolimus (FK506) proves superior to OKT3 for treating episodes of persistent rejection following intrathoracic transplantation. Meiser BM; Uberfuhr P; Schulze C; Fuchs A; Mair H; Reichenspurner H; Kreuzer E; Reichart B Transplant Proc; 1997; 29(1-2):605-6. PubMed ID: 9123150 [No Abstract] [Full Text] [Related]
4. Comparison between three different antilymphocyte induction protocols in renal transplant recipients with delayed graft function. Sumrani N; Hong JH; DiBenedetto A; Clayton R; Miles AM; Markell MS; Distant DA; Fleishhacker J; Sommer BG Transplant Proc; 1996 Feb; 28(1):400-1. PubMed ID: 8644289 [No Abstract] [Full Text] [Related]
5. Treatment of steroid resistant acute rejection after renal transplantation. Oh CK; Kim YS; Kim MS; Kim SI; Park K Transplant Proc; 1996 Jun; 28(3):1453-4. PubMed ID: 8658737 [No Abstract] [Full Text] [Related]
7. ATG versus OKT3 in the treatment of steroid-resistant rejection following living-related donor renal transplantation. Uslu A; Tokat Y; Ok E; Unsal A; Ilkgul O; Kaplan H Transplant Proc; 1997 Nov; 29(7):2805-6. PubMed ID: 9365571 [No Abstract] [Full Text] [Related]
9. Treatment of steroid-resistant and recurrent acute cardiac transplant rejection with a short course of antibody therapy. Cantarovich M; Latter DA; Loertscher R Clin Transplant; 1997 Aug; 11(4):316-21. PubMed ID: 9267721 [TBL] [Abstract][Full Text] [Related]
10. How successful is OKT3 rescue therapy for steroid-resistant acute rejection episodes after heart transplantation? Wagner FM; Reichenspurner H; Uberfuhr P; Kur F; Kaulbach HG; Meiser BM; Ziegler U; Reichart B J Heart Lung Transplant; 1994; 13(3):438-42; discussion 442-3. PubMed ID: 8061020 [TBL] [Abstract][Full Text] [Related]
11. Long-term outcome with the use of OKT3 induction therapy in heart transplant patients: a single-center experience. Adamson R; Obispo E; Dychter S; Dembitsky W; Moreno-Cabral R; Jaski B; Gordon J; Hoagland P; Moore K; King J; Andrews J; Rich M; Daily PO Transplant Proc; 1998 Jun; 30(4):1107-9. PubMed ID: 9636449 [No Abstract] [Full Text] [Related]
12. Photopheresis for recurrent acute rejection in cardiac transplantation. Giunti G; Schürfeld K; Maccherini M; Tanganelli P; Rubegni P; Alfani D; D'Ascenzo G; Diciolla F; Bernazzali S; Fimiani M; Toscano M; Sani G Transplant Proc; 1999; 31(1-2):128-9. PubMed ID: 10083041 [No Abstract] [Full Text] [Related]
13. Effectiveness of immunosuppressive treatment for recurrent or refractory pancreas allograft rejection: correlation with histologic grade. Papadimitriou JC; Wiland A; Drachenberg CB; Klassen DK; Bartlett ST Transplant Proc; 1998 Dec; 30(8):3945. PubMed ID: 9865254 [No Abstract] [Full Text] [Related]